14-day Premium Trial Subscription Sign Up For FreeGet Free

Aptose Biosciences Stock Forecast NASDAQ:APTO

Price Target and Analyst Ratings

Most Recent Rating

Piper Sandler is very positive about APTO and gave it a "Overweight" rating on July 05, 2021. The price target was changed from $12.00 to $7.00.

Last 30 Days

Historical Ratings

Date Rating Action Authority Current Price Target Price
2021-07-05 Overweight Target Lowered by Piper Sandler $3.34 $12.00 → $7.00
2021-03-30 Outperform Target Raised by Oppenheimer $6.22 $8.00 → $9.00
2021-03-24 Outperform Target Raised by Oppenheimer $6.10 $8.00 → $9.00
2021-02-22 Buy Initiated by Jonestrading $4.30 $14.00
2020-10-20 Buy Reiterated by Canaccord Genuity $5.65 $13.00
2020-10-19 Overweight Initiated by Cantor Fitzgerald $5.71 $10.00
2020-10-19 Overweight Initiated by Cantor Fitzgerald $5.71
2020-09-22 Buy Initiated by Alliance Global Partners $6.25 $12.00
2020-06-23 Overweight Reiterated by Piper Sandler $6.90 $10.00
2020-06-14 Buy Initiated by Oppenheimer $6.73 $9.00
2020-06-12 Buy Reiterated by HC Wainwright $6.73 $9.00
2020-04-27 Buy Reiterated by HC Wainwright $7.34 $9.00

APTO Stock Trend

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled.

Given the current short-term trend, the stock is expected to fall -17.13% during the next 3 months and, with a 90% probability hold a price between $1.78 and $2.48 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Data

Date Bottom Mid Top
2021-09-20 $2.14 $2.56 $2.98
2021-09-21 $2.13 $2.55 $2.97
2021-09-22 $2.12 $2.54 $2.96
2021-09-23 $2.11 $2.53 $2.95
2021-09-24 $2.10 $2.52 $2.94
2021-09-27 $2.09 $2.51 $2.93
2021-09-28 $2.09 $2.50 $2.92
2021-09-29 $2.08 $2.49 $2.91
2021-09-30 $2.07 $2.48 $2.90
2021-10-01 $2.06 $2.47 $2.89
2021-10-04 $2.05 $2.46 $2.88
2021-10-05 $2.04 $2.46 $2.87
2021-10-06 $2.03 $2.45 $2.86
2021-10-07 $2.02 $2.44 $2.85
2021-10-08 $2.01 $2.43 $2.84
2021-10-11 $2.00 $2.42 $2.83
2021-10-12 $1.99 $2.41 $2.83
2021-10-13 $1.98 $2.40 $2.82
2021-10-14 $1.97 $2.39 $2.81
2021-10-15 $1.96 $2.38 $2.80
2021-10-18 $1.95 $2.37 $2.79
2021-10-19 $1.94 $2.36 $2.78
2021-10-20 $1.93 $2.35 $2.77
2021-10-21 $1.92 $2.34 $2.76
2021-10-22 $1.91 $2.33 $2.75
2021-10-25 $1.90 $2.32 $2.74
2021-10-26 $1.89 $2.31 $2.73
2021-10-27 $1.88 $2.30 $2.72
2021-10-28 $1.87 $2.29 $2.71
2021-10-29 $1.86 $2.28 $2.70

About Aptose Biosciences

Aptose Biosciences Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology in Canada. Its lead clinical program is APTO-253, a small molecule that induces the transcription of the Krüppel-like factor 4 Gene in in vitro studies and in in vivo pharmacodynamic studies of human xenograft tumors in mice. The company’s APTO-253 clinical program has completed Phase-I clinic... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 95.000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT